A Trial to Evaluate HbA1c Reduction after 8 Weeks Ingestion of Inulin-Containing Food - Double Blind Randomized Placebo-Controlled Parallel Group Study - - A Trial to Evaluate HbA1c Reduction after 8 Weeks Ingestion of Inulin-Containing Food

Medical Corporation Hokubukai Utsukushigaoka Hospital0 个研究点目标入组 20 人开始时间: 2019年10月29日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1)Individuals who have history of serious gastrointestinal disease, liver disease, kidney disease, cardiovascular disease, blood disease, endocrine system disease, or malignant neoplasm, or individuals who are suspected to have these diseases. (2) Individuals currently taking oral medication for internal diseases or receiving medical treatment. (3) Individuals planning to take medicine or to receive medical treatment during in this study. (4) Individuals planning to continuously take health food product or a supplement that indicates reduction of blood glucose and/or diabetes prevention during this study. (5) Individuals who have possibility of changing a lifestyle (i.e. night work, long travel or transfer) (6) Individuals with excessive alcohol drinking or heavy smoking (7) Individuals who may have allergies to Asteraceae plants in relation to the test food. (8) Individuals currently participating or planning to participate in any other clinical studies. (9) Individuals judged as inappropriate for the trial by the principal investigator.

发起方

Medical Corporation Hokubukai Utsukushigaoka Hospital